Spots Global Cancer Trial Database for Impact of Catch-up HPV Vaccination

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Impact of Catch-up HPV Vaccination

Official Title: Impact of Catch-up HPV Vaccination on the Development of Cervical Lesions

Study ID: NCT05462249

Conditions

HPV

HPV Vaccination

Vaccine Preventable Disease

Cervical Lesion

Cervical Cancer

Interventions

Study Description

Brief Summary: Each year in France, more than 6000 new cases of HPV inducted cancers are recorded. The vaccinal cover stays insufficient since less than 30% of the french population is vaccinated. Therefore french studies about vaccine efficacy and especially about the catch-up vaccine (done after 15years old) are needed. HPVAC2 is a prospective, analytic and monocentric study designed to learn the impact of the catch-up HPV vaccination. Women from 25 years old and born after 1984 may be included if they come to the Brest CHU to do their regular cervical smear. At this time, a survey will be given to know their vaccinal status. The aim of the study is to prove the efficacy of the catch up vaccination by analyzing the cervical smears results and by comparing the vaccinated group with the not-vaccinated group.

Detailed Description: